About The Medical Condition Evaluation Studies, FDA Phase III
Find the definition of the medical term Evaluation Studies, FDA Phase III. Evaluation Studies, FDA Phase III defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Evaluation Studies, FDA Phase III
| Evaluation Studies, FDA Phase III Medical Condition |
|---|
What's The Definition Of The Medical Condition Evaluation Studies, FDA Phase III?
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Annular Groove ‐ A disorder present in the newborn infant in which constriction…
- Monograph (PT) ‐ In cataloging, any publication that is not a serial. It is usually…
- Associated Fibril-Protein, Scrapie ‐ Protease-resistant core of PrPSC, the abnormal isoform of prion…
- Germ Layers ‐ The three layers of cells comprising the…
- Uroporphyrinogen Synthetase ‐ An enzyme that catalyzes the formation of hydroxymethylbilane…
- Deficiency Disease Hexosaminidase A ‐ An autosomal recessive inherited gangliosidosis characterized…
- Pharmacy Education, Continuing ‐ Educational programs designed to inform graduate pharmacists…
- Organisms, GMO ‐ Organisms whose GENOME has been changed by a GENETIC ENGINEERING…
- Lyase, Chondroitin Sulfate ‐ Enzymes which catalyze the elimination of delta-4,5-D-glucuronate…
- Induced Hypothermia ‐ Abnormally low body temperature intentionally induced in warm-blooded…